Navigation Links
BBVA Foundation international study on attitudes to stem cell research
Date:5/14/2008

Madrid, May 13, 2008.-Unlike most scientific and technological advances, which tend to take their place silently in society, biotechnology often finds itself the center of public debate and regulatory attention, due partly to the moral issues posed by many of its applications.

In this second BBVA Foundation international study on Attitudes to Biotechnology (the first was in 2003), the sample has been enlarged from nine to twelve European countries (Austria, Czech Republic, Germany, Denmark, Spain, France, Ireland, Italy, Netherlands, Poland, United Kingdom and Sweden), with the addition of countries from other continents; namely the United States, Japan and Israel. The selection of countries was informed by both their demographical weight and their variability from the standpoint of religious beliefs and cultural traditions.

Information was gathered through 1,500 face-to-face interviews in each country with subjects aged 18 and over (around 22,500 interviewees in all) conducted between April 2007 and February 2008. The design and analysis of the survey were the work of the Department of Social Studies and Public Opinion of the BBVA Foundation.

The present study focuses on attitudes towards one biotechnology application: research with embryos for the purpose of obtaining stem cells. In particular, it analyzes how far public opinion is informed about stem cells, expectations and reservations regarding research with embryonic stem cells and differences in support for such research depending on the origin of the embryos used. Attention also goes to the attitudes held on the creation of hybrid embryos for stem cell research.

PUBLIC UNDERSTANDING OF THE NATURE OF STEM CELLS

The data show that the percentage of the population that admit having heard or read anything about this kind of cell was notably uneven across the survey countries: over 70% had heard or read about stem cells in Sweden and Denmark (86%), and als
'/>"/>

Contact: Communication Department
comunicacion@fbbva.es
Fundacin BBVA
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Landon Foundation-AACR INNOVATOR Awards
2. National Lung Cancer Partnership and LUNGevity Foundation
3. UTSA receives $822,000 from Kleberg Foundation to enhance scientific research
4. Cummings School receives Rockefeller Foundation grant
5. Helios Education Foundation invests $6.5 million
6. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
7. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
8. CONRAD receives $28.5M Gates Foundation grant for HIV prevention research
9. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
10. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
11. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
(Date:8/5/2015)... Aug. 5, 2015 The biosensors market is ... applications, penetration into newer sectors, and development of devices ... biosensors space has seen the entry of multiple participants ... far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( http://www.frost.com/nee9 ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... of Southern California (USC) professor Mary Ann Pentz, Ph.D., shows ... are more likely to drink alcohol in high school than ... September-October 2011 issue of the journal Alcohol and Alcoholism ... that may benefit from special prevention programs. "As you ...
... research technology is revealing how humans develop immunity ... eradicating this parasitic disease. Dr Alyssa Barry ... and Immunity division is using ,protein microarray, technology ... to proteins produced by the malaria-causing Plasmodium falciparum ...
... in studies of pentosuria, an inherited disorder once mistaken ... their lives. Their willingness to have their DNA analyzed ... than a hundred years old. Researchers from ... solution in the Oct. 31 Early Edition of the ...
Cached Biology News:Underage drinking among close friends high indicator of future alcohol use by black teens 2'Protein microarrays' may reveal new weapons against malaria 2Modern genetics answers age-old question on Garrod's fourth inborn error of metabolism 2Modern genetics answers age-old question on Garrod's fourth inborn error of metabolism 3Modern genetics answers age-old question on Garrod's fourth inborn error of metabolism 4
(Date:9/1/2015)... , Sept. 1, 2015 The Dohmen ... Floyd , Ph.D., MBA as Chief Science Officer ... this newly created role, Dr. Floyd will lead ... a portfolio of pre-commercial and post approval outsourced ... and medical communications.  Dr. Floyd brings decades of ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Director of Business Development, Asia Pacific. In this newly-created position, Gibbs will lead ... and use of iLab’s suite of tools. This entails not only introducing iLab ...
(Date:9/1/2015)... , September 1, 2015 Shire plc ... Sara Mathew to its Board of Directors as ... the Audit, Compliance & Risk Committee of the Shire Board. ... Sara previously served as Chairman, President and Chief ... December 2013. During her 12-year tenure at D&B, she helped ...
(Date:8/31/2015)... 31, 2015 MabVax Therapeutics Holdings, Inc. (OTCQB: ... the Company,s lead antibody, HuMab 5B1, will be garnering ... during the upcoming World Molecular Imaging Congress (WMIC) being ... 2015. Researchers from the Department of Radiology at Memorial ... the use of MabVax,s lead antibody as a PET ...
Breaking Biology Technology:Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3Shire Appoints Sara Mathew to Board of Directors 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 3MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 4
... (Nasdaq: NXTM ), a leading manufacturer of ... current summary,information derived from a registry of NxStage ... home on a more frequent,or daily, basis as ... three times a week at a dialysis center., ...
... Intent to Grant Patent, LONDON, July 23 ... RNAi focused biotechnology company, today announces new,intellectual property ... Office announced on July 17, 2008 that it ... internal product candidate. This,patent will give Silence broad ...
... Calif., July 22 CV Therapeutics,Inc. (Nasdaq: CVTX ... results for 2008 after the market closes on Thursday, ... at 5:00 p.m. EDT,2:00 p.m. PDT, on the company,s ... on to the Company,s website at, http://www.cvt.com and ...
Cached Biology Technology:NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 2NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 3NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 4NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population 5Silence Obtains Important Patent Protection for Lead Internal Development Compound, Atu027 2Silence Obtains Important Patent Protection for Lead Internal Development Compound, Atu027 3CV Therapeutics to Announce 2008 Second Quarter Financial Results on Thursday, July 31, 2008 2
Tight junctions are complexes of proteins that create intercellular boundaries between the plasma membrane domains of epithelial and endothelial cells. Antigen: Synthetic peptide corresponding to...
Myeloid Marker (BM-1)...
Form: Concentrated Applications: ELISA...
Request Info...
Biology Products: